Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement
- PMID: 37071089
- DOI: 10.1001/jama.2023.4342
Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement
Abstract
Importance: Skin cancer is the most commonly diagnosed cancer in the US. There are different types of skin cancer varying in disease incidence and severity. Basal and squamous cell carcinomas are the most common types of skin cancer but infrequently lead to death or substantial morbidity. Melanomas represent about 1% of skin cancer and cause the most skin cancer deaths. Melanoma is about 30 times more common in White persons than in Black persons. However, persons with darker skin color are often diagnosed at later stages, when skin cancer is more difficult to treat.
Objective: To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on the benefits and harms of screening for skin cancer in asymptomatic adolescents and adults.
Population: Asymptomatic adolescents and adults who do not have a history of premalignant or malignant skin lesions.
Evidence assessment: The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in asymptomatic adolescents and adults.
Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults. (I statement).
Summary for patients in
-
Screening and Prevention of Skin Cancer.JAMA. 2023 Apr 18;329(15):1324. doi: 10.1001/jama.2023.4045. JAMA. 2023. PMID: 37071093
Similar articles
-
Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2016 Jul 26;316(4):429-35. doi: 10.1001/jama.2016.8465. JAMA. 2016. PMID: 27458948
-
Skin Cancer Screening: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2023 Apr 18;329(15):1296-1307. doi: 10.1001/jama.2023.3262. JAMA. 2023. PMID: 37071090
-
Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2018 Mar 20;319(11):1134-1142. doi: 10.1001/jama.2018.1623. JAMA. 2018. PMID: 29558558
-
Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement.JAMA. 2021 Sep 14;326(10):949-956. doi: 10.1001/jama.2021.14081. JAMA. 2021. PMID: 34519796
-
Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Jun 21;327(23):2326-2333. doi: 10.1001/jama.2022.8970. JAMA. 2022. PMID: 35727271 Review.
Cited by
-
The skinny on skin: The role of skin-aware professionals in skin cancer surveillance.J Cosmet Dermatol. 2024 Dec;23(12):4173-4201. doi: 10.1111/jocd.16536. Epub 2024 Sep 1. J Cosmet Dermatol. 2024. PMID: 39219284 Free PMC article.
-
Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case-Control Study.Cancers (Basel). 2024 Jun 15;16(12):2233. doi: 10.3390/cancers16122233. Cancers (Basel). 2024. PMID: 38927938 Free PMC article.
-
Patients' Characteristics and Environmental Factors Affecting Skin Cancer Detection: A Multicentre Prospective Study.Acta Derm Venereol. 2023 Aug 22;103:adv11933. doi: 10.2340/actadv.v103.11933. Acta Derm Venereol. 2023. PMID: 37605894 Free PMC article. No abstract available.
-
Outcomes and Follow-Up Data From Two Skin Cancer Screening Events.Cureus. 2023 Aug 22;15(8):e43938. doi: 10.7759/cureus.43938. eCollection 2023 Aug. Cureus. 2023. PMID: 37746437 Free PMC article.
-
Skin Cancer Diagnosis by Lesion, Physician, and Examination Type: A Systematic Review and Meta-Analysis.JAMA Dermatol. 2025 Feb 1;161(2):135-146. doi: 10.1001/jamadermatol.2024.4382. JAMA Dermatol. 2025. PMID: 39535756
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical